Legend Biotech Corp - ADR logo

LEGN

Legend Biotech Corp - ADR

$45.32

Earnings Summary

Revenue
$40.83Mn
Net Profits
$-41.09Mn
Net Profit Margins
-100.64%

Highlights

Revenue:

Legend Biotech Corp - ADR’s revenue jumped 198.4% since last year same period to $40.83Mn in the Q1 2022. On a quarterly growth basis, Legend Biotech Corp - ADR has generated 4.7% jump in its revenue since last 3-months.

Net Profits:

Legend Biotech Corp - ADR’s net profit jumped 49.21% since last year same period to $-41.09Mn in the Q1 2022. On a quarterly growth basis, Legend Biotech Corp - ADR has generated 53.49% jump in its net profits since last 3-months.

Net Profit Margins:

Legend Biotech Corp - ADR’s net profit margin jumped 82.98% since last year same period to -100.64% in the Q1 2022. On a quarterly growth basis, Legend Biotech Corp - ADR has generated 55.57% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Legend Biotech Corp - ADR post its latest quarter earnings

EPS Estimate Current Quarter
-0.29
EPS Estimate Current Year
-0.29

Highlights

EPS Estimate Current Quarter:

Legend Biotech Corp - ADR’s earning per share (EPS) estimates for the current quarter stand at -0.29 - a 36.96% jump from last quarter’s estimates.

EPS Estimate Current Year:

Legend Biotech Corp - ADR’s earning per share (EPS) estimates for the current year stand at -0.29.

Key Ratios

Key ratios of the Legend Biotech Corp - ADR post its Q1 2022 earnings

Earning Per Share (EPS)
-0.13
Return on Assets (ROA)
-0.28
Return on Equity (ROE)
-1.07
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Legend Biotech Corp - ADR’s earning per share (EPS) jumped 56.67% since last year same period to -0.13 in the Q1 2022. This indicates that the Legend Biotech Corp - ADR has generated 56.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Legend Biotech Corp - ADR’s return on assets (ROA) stands at -0.28.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Legend Biotech Corp - ADR’s return on equity (ROE) stands at -1.07.

Dividend Per Share (DPS):

Legend Biotech Corp - ADR declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-03-31
-0.46
-0.13
71.74%

Company Information

Legend Biotech is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. The team of over 800 employees across the United States, China and Europe, along with its differentiated technology, global development, and manufacturing strategies and expertise, provide us with the strong potential to discover, develop, and manufacture cutting edge cell therapies for patients in need.

Organisation
Legend Biotech Corp - ADR
Headquarters
Somerset, New Jersey, United States
Employees
2.02K
Industry
Commercial Services